Cumberland Pharmaceuticals Inc (CPIX)
1.175
+0.04
(+3.07%)
USD |
NASDAQ |
Nov 05, 11:37
Cumberland Pharmaceuticals Debt to Equity Ratio: 0.6107 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.6107 |
| March 31, 2024 | 0.5851 |
| December 31, 2023 | 0.4318 |
| September 30, 2023 | 0.3591 |
| June 30, 2023 | 0.3538 |
| March 31, 2023 | 0.442 |
| December 31, 2022 | 0.4467 |
| September 30, 2022 | 0.4566 |
| June 30, 2022 | 0.4815 |
| March 31, 2022 | 0.4875 |
| December 31, 2021 | 0.3504 |
| September 30, 2021 | 0.3204 |
| June 30, 2021 | 0.292 |
| March 31, 2021 | 0.319 |
| December 31, 2020 | 0.3658 |
| September 30, 2020 | 0.3547 |
| June 30, 2020 | 0.3507 |
| March 31, 2020 | 0.3708 |
| December 31, 2019 | 0.3619 |
| September 30, 2019 | 0.3866 |
| June 30, 2019 | 0.37 |
| March 31, 2019 | 0.3608 |
| December 31, 2018 | 0.3581 |
| September 30, 2018 | 0.2062 |
| June 30, 2018 | 0.2003 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.1964 |
| December 31, 2017 | 0.1528 |
| September 30, 2017 | 0.1229 |
| June 30, 2017 | 0.1005 |
| March 31, 2017 | 0.0567 |
| December 31, 2016 | 0.056 |
| September 30, 2016 | 0.0496 |
| June 30, 2016 | 0.047 |
| March 31, 2016 | 0.0225 |
| December 31, 2015 | 0.0221 |
| September 30, 2015 | 0.0219 |
| June 30, 2015 | 0.0216 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.0599 |
| June 30, 2013 | 0.0706 |
| March 31, 2013 | 0.0512 |
| December 31, 2012 | 0.0509 |
| September 30, 2012 | 0.0522 |
| June 30, 2012 | 0.0523 |
| March 31, 2012 | 0.0624 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.292
Minimum
Jun 2021
0.6107
Maximum
Jun 2024
0.4074
Average
0.3658
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 78.52M |
| Total Liabilities (Quarterly) | 52.49M |
| Shareholders Equity (Quarterly) | 26.35M |
| Current Ratio | 1.437 |
| Net Debt Paydown Yield | -0.02% |